PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours-Reference-Cited by-同舟云学术

PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours

Published:2022-05 Issue: Volume:19 Page:101381
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Davern Maria^ORCID,Fitzgerald Marie-Claire^ORCID,Buckley Croí E.^ORCID,Heeran Aisling B.^ORCID,Donlon Noel E.,McGrath Jason^ORCID,O’ Connell Fiona^ORCID,Deshpande Malvika R.,Hayes Conall^ORCID,MacDonald Jamie,Sheppard Andrew D.,Reynolds John V.,Maher Stephen G.^ORCID,Lynam-Lennon Niamh,Murphy Brona^ORCID,Lysaght Joanne^ORCID

Funder

Irish Research Council

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth;Kleffel;Cell,2015

2. Expression of programmed cell death protein 1 by tumor-infiltrating lymphocytes and tumor cells is associated with advanced tumor stage in patients with esophageal adenocarcinoma;Kollmann;Ann. Surg. Oncol.,2017

3. Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer;Gao;Br. J. Cancer,2019

4. Elevated cellular PD1/PD-L1 expression confers acquired resistance to cisplatin in small cell lung cancer cells;Yan;PLoS ONE,2016

5. Tim-3 expression in cervical cancer promotes tumor metastasis;Cao;PLoS ONE,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function;Immunity;2024-08

2. Multifaceted roles of PD‐1 in tumorigenesis: From immune checkpoint to tumor cell‐intrinsic function;Molecular Carcinogenesis;2024-05-15

3. Targeting TIGIT for cancer immunotherapy: recent advances and future directions;Biomarker Research;2024-01-16

4. Immunotherapy for hepatocellular carcinoma: molecular pathogenesis and clinical research progress;Oncology and Translational Medicine;2023-12-22

5. The future of combination immunotherapy in oesophageal adenocarcinoma;Frontiers in Immunology;2023-07-14